Sanofi files US antitrust lawsuit against Mylan over EpiPen
New Jersey: Sanofi SA on Monday sued Mylan NV, accusing the pharmaceutical company of engaging in illegal conduct to squelch competition to its EpiPen allergy treatment, which has been at the center of a public debate over drug prices.
In a lawsuit filed in federal court in Trenton, New Jersey, Sanofi said that Mylan's conduct has resulted in the company losing hundreds of millions of dollars in sales for a rival product, Auvi-Q.
(Reporting by Nate Raymond in Boston)
In a lawsuit filed in federal court in Trenton, New Jersey, Sanofi said that Mylan's conduct has resulted in the company losing hundreds of millions of dollars in sales for a rival product, Auvi-Q.
(Reporting by Nate Raymond in Boston)
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd